Article
Molecular genetics of PKU in Poland and potential impact of mutations on BH4 responsiveness.
Acta biochimica Polonica - 1 Jan 2013
Bik-Multanowski Miroslaw, Kaluzny Lukasz, Mozrzymas Renata, Oltarzewski Mariusz, Starostecka Ewa, Lange Agata, Didycz Bozena, Gizewska Maria, Ulewicz-Filipowicz Jolanta, Chrobot Agnieszka, Mikoluc Bozena, Szymczakiewicz-Multanowska Agnieszka, Cichy Wojciech, Pietrzyk Jacek J
Abstract excerpt
Tetrahydrobiopterin (BH4) has been recently approved as a treatment of patients with phenylketonuria. However, as a confirmation of BH4-responsiveness, it might require a very expensive trial treatment with BH4 or prolonged BH4-loading procedures. The selection of patients eligible for BH4-therapy by means of genotyping of the PAH gene mutations may be recommended as a complementary approach. A population-wide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
